RBP4 and Alzheimer disease: The Retinol-binding protein 4 (RBP4), found to be reduced in 4 out of 5 studies, can circulate as an adipokine, and is related to insulin metabolism and retinoic acid signalling, both AD-associated processes [63, 64].